Skip to main content
menu

UGYO17017 / MD Anderson / Richard Moore

Research Question:
Can the blood test, CA-125 be helpful in the early detection of ovarian cancer in women who are at low risk?

Basic Study Information

Purpose:
The goal of this clinical research study is to evaluate a method involving 4 blood tests called CA-125, HE4, HE4 antigen autoantibody complexes, and osteopontin that may be helpful in the early detection of ovarian cancer in women who are at low risk.

Location: Cancer Center
Study Web URL:  https://clinicaltrials.gov/ct2/show/NCT00539162?term=ID01-022&rank=1
Study Reference #: UGYO17017

Lead Researcher (Principal Investigator)

Lead Researcher:  Richard Moore

Study Contact Information

Study Contact: Clinical Trials Office
Study Location: Wilmot Cancer Institute, University of Rochester Medical Center
Study Email: WCICTOResearch@urmc.rochester.edu

Additional Study Details

Return to Search